1981.
Response to “It could have been much worse: The Minnesota measles outbreak of 2017”
by Ehresmann, Kristen
Vaccine, 2019-01-29, Vol.37 (5), p.683-684

1982.
Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis–hydropericardium syndrome (HHS)
by Schachner, Anna
Vaccine, 2013, Vol.32 (9), p.1086-1092

1983.
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
by Reed, Carrie
Vaccine, 2012, Vol.30 (11), p.1993-1998

1984.
Pneumonia endpoints must be standardized for adult pneumococcal vaccine trials
by Suzuki, Motoi
Vaccine, 2020-12-14, Vol.38 (52), p.8259-8259

1985.
Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system
by Correia, Ricardo
Vaccine, 2021-06-02, Vol.39 (24), p.3279-3286

1986.
Vaccination policies for healthcare workers in Europe
by Maltezou, Helena C
Vaccine, 2013, Vol.32 (38), p.4876-4880

1987.
Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine
by Esparza, José
Vaccine, 2017-12-19, Vol.35 (52), p.7222-7230

1988.
Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice
by Zhang, Xiaoli
Vaccine, 2018-02-14, Vol.36 (8), p.1047-1054

1989.
Strategies to increase vaccine acceptance and uptake: From behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions
by Thomson, Angus
Vaccine, 2018-10-22, Vol.36 (44), p.6457-6458

1990.
A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge
by Pallister, Jackie
Vaccine, 2011, Vol.29 (34), p.5623-5630

1991.
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study
by Maltezou, Helena C
Vaccine, 2021-11-26, Vol.39 (48), p.7021-7027

1992.
The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in rural Kenya
by Wakadha, Hotenzia
Vaccine, 2012, Vol.31 (6), p.987-993

1993.
Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
by Frasch, Carl E
Vaccine, 2009, Vol.27, p.B112-B116

1994.
Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States
by Guntuku, Sharath Chandra
Vaccine, 2021-07-05, Vol.39 (30), p.4034-4038

1995.
Understanding immunosenescence and its impact on vaccination of older adults
by Allen, Jessica C
Vaccine, 2020-12-14, Vol.38 (52), p.8264-8272

1996.
Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine
by Hegerle, N
Vaccine, 2014, Vol.32 (49), p.6597-6600

1997.
Ethical trade-offs in vaccine development and distribution—Response to Gurwitz
by Rid, Annette
Vaccine, 2021-02-12, Vol.39 (7), p.1028-1029

1998.
Willingness to pay and financing preferences for COVID-19 vaccination in China
by Wang, Jiahao
Vaccine, 2021-04-01, Vol.39 (14), p.1968-1976

1999.
Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia
by Harapan, Harapan
Vaccine, 2019-03-07, Vol.37 (11), p.1398-1406

2000.
Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population
by Atsmon, Jacob
Vaccine, 2014, Vol.32 (44), p.5816-5823
